New Key Statistics Module, Z-Score and F-Score
NAS:GLUE Key Ratios
Market Cap $ M | 252.56 |
Enterprise Value $ M | 102.32 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 1.63 |
Price/Sales | 275.00 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 1.00 |
EPS (TTM) $ | -2.52 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -0.71 |
EV-to-EBITDA | -0.75 |
PEG | -- |
Shares Outstanding M | 50.51 |
Net Margin (%) | -12,714.47 |
Operating Margin % | -13,533.65 |
Pre-tax Margin (%) | -12,674.81 |
Quick Ratio | 4.82 |
Current Ratio | 4.82 |
ROA % (ttm) | -47.96 |
ROE % (ttm) | -69.47 |
ROIC % (ttm) | -166.26 |
Dividend Yield % | -- |
Altman Z-Score | -1.73 |
GLUE Number of Guru Trades
GLUE Volume of Guru Trades
Gurus Latest Trades with NAS:GLUE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:GLUE is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Monte Rosa Therapeutics Inc Insider Transactions
No Available Data
News about NAS:GLUE
Total 0- 1